More about High-Yield Cash Accounts with M1
Brokerage Accounts
Retirement Accounts
Other Accounts
Quotes are delayed by 15 minutes.
1D
1W
1M
3M
6M
YTD
1Y
2Y
5Y
ALL
Market cap
$6.62B
EPS
19.88
P/E ratio
25.8
Price to sales
2.59
Dividend yield
0.553%
Beta
0.507523
Previous close
$514.29
Today's open
$511.55
Day's range
$499.18 - $511.55
52 week range
$365.21 - $557
show more
CEO
Kevin J. McNamara
Employees
15811
Headquarters
Cincinnati, OH
Exchange
New York Stock Exchange
Shares outstanding
13069961
Issue type
Common Stock
Healthcare
Healthcare Providers & Services
Roto-Rooter Buys Largest Franchisee Territory
CINCINNATI, Sept. 16, 2026 (GLOBE NEWSWIRE) -- Roto-Rooter Services Company, a wholly owned subsidiary of Chemed Corporation ("Chemed") (NYSE: CHE) announced it has acquired the largest independent Roto-Rooter franchise, serving a population of approximately 11 million people, for $60.6 million.
GlobeNewsWire • 7 hours ago

Chemed Corporation (CHE) Presents at 2026 Jefferies Healthcare Services and Technology Conference Transcript
Chemed Corporation (CHE) Presents at 2026 Jefferies Healthcare Services and Technology Conference Transcript
Seeking Alpha • Sep 15, 2026

Chemed Corporation to Present at the Jefferies 2026 Healthcare Services Conference
CINCINNATI, Sept. 08, 2026 (GLOBE NEWSWIRE) -- Chemed Corporation (NYSE: CHE) today announced that it will deliver a presentation at the Jefferies 2026 Healthcare Services and Technology Conference on Tuesday, September 15, 2026, at approximately 10:55 a.m.
GlobeNewsWire • Sep 8, 2026

Chemed Executive Spencer Lee Sells 1,000 Shares for $541,040
The sale occurred on Aug. 21 and was valued at approximately $541,000. The disposition reduced the executive's direct equity holdings by 7%.
The Motley Fool • Sep 6, 2026

CHEMED CORPORATION INVESTOR ALERT: Scott+Scott Attorneys at Law LLP Investigates Chemed Corporation's Directors and Officers for Breach of Fiduciary Duties – CHE
NEW YORK--(BUSINESS WIRE)---- $CHE #NYSE--Scott+Scott Attorneys at Law LLP has launched an urgent investigation into whether certain officers and directors of Chemed Corporation (NYSE: CHE) failed to manage Chemed in an acceptable manner, breaching their fiduciary duties to Chemed, and whether Chemed and its shareholders have suffered damages as a result. Attorney Joseph A. Pettigrew is heading the investigation—what shareholders need to know: On August 13, 2026, The Capital Forum released a report alleging t.
Business Wire • Sep 3, 2026

Chemed (CHE) Up 1.7% Since Last Earnings Report: Can It Continue?
Chemed (CHE) reported earnings 30 days ago. What's next for the stock?
Zacks Investment Research • Aug 27, 2026

OPCH or CHE: Which Is the Better Value Stock Right Now?
Investors looking for stocks in the Medical - Outpatient and Home Healthcare sector might want to consider either Option Care (OPCH) or Chemed (CHE). But which of these two stocks presents investors with the better value opportunity right now?
Zacks Investment Research • Aug 25, 2026

CHEMED CORPORATION INVESTOR ALERT: Scott+Scott Attorneys at Law LLP Investigates Chemed Corporation's Directors and Officers for Breach of Fiduciary Duties – CHE
NEW YORK--(BUSINESS WIRE)---- $CHE #NYSE--Scott+Scott Attorneys at Law LLP has launched an urgent investigation into whether certain officers and directors of Chemed Corporation (NYSE: CHE) failed to manage Chemed in an acceptable manner, breaching their fiduciary duties to Chemed, and whether Chemed and its shareholders have suffered damages as a result. Attorney Joseph A. Pettigrew is heading the investigation—what shareholders need to know: On August 13, 2026, The Capital Forum released a report alleging t.
Business Wire • Aug 20, 2026

Chemed Corporation Declares Quarterly Dividend of 70 Cents
CINCINNATI, Aug. 06, 2026 (GLOBE NEWSWIRE) -- Chemed Corporation (NYSE:CHE) announced today that the Board of Directors has declared a quarterly cash dividend of 70-cents per share on the Company's capital stock, payable on September 3, 2026, to shareholders of record as of August 17, 2026. This is a 10-cent, or 17%, increase over the 60-cent dividend paid in June 2026.
GlobeNewsWire • Aug 6, 2026

Chemed Corporation: Why A Spin-Off Could Unlock Its Hidden Value
Chemed Corporation (CHE) receives a Buy rating with a $632/share target, driven by activist pressure for a spin-off to eliminate the conglomerate discount. VITAS has successfully reengineered its patient mix, sharply reducing Medicare Cap penalties and driving 8.8% revenue growth and 18.2% Adjusted EBITDA margin in Q2. Roto-Rooter faces structural margin pressure from rising digital marketing costs, but B2B expansion and operational efficiencies are expected to support future growth.
Seeking Alpha • Aug 5, 2026

¹ Disclosures

Open an M1 investment account to buy and sell Chemed Corp commission-free¹. Build wealth for the long term using automated trading and transfers.